🇺🇸 FDA
Pipeline program

Sirolimus

SMART_V2.2

Approved small_molecule active

Quick answer

Sirolimus for Antiphospholipid (aPL)-Positive is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Antiphospholipid (aPL)-Positive
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials